{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:58:27Z","timestamp":1779361107241,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.conctc.2025.101471","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T03:54:48Z","timestamp":1742010888000},"page":"101471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Impact of a digital platform and flare risk blood biomarker index on lupus: A study protocol design for evaluating self efficacy and disease management"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6868-4742","authenticated-orcid":false,"given":"Eldon R.","family":"Jupe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohan","family":"Purushothaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5821-4253","authenticated-orcid":false,"given":"Gerald","family":"Lushington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay R.","family":"Nadipelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6933-9745","authenticated-orcid":false,"given":"Melissa E.","family":"Munroe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Crawley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sneha","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arif","family":"Sorathia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett","family":"Adelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.conctc.2025.101471_bib1","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/art.41632","article-title":"Prevalence of systemic lupus erythematosus in the United States: estimates from a meta-analysis of the centers for disease control and prevention national lupus registries","volume":"73","author":"Izmirly","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.conctc.2025.101471_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/art.38239","article-title":"The incidence and prevalence of systemic lupus erythematosus, 2002-2004: the Georgia Lupus Registry","volume":"66","author":"Lim","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.conctc.2025.101471_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.38238","article-title":"Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program","volume":"66","author":"Somers","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.conctc.2025.101471_bib4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrrheum.2016.137","article-title":"The global burden of SLE: prevalence, health disparities and socioeconomic impact","volume":"12","author":"Carter","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"11","key":"10.1016\/j.conctc.2025.101471_bib5","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.conctc.2025.101471_bib6","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.conctc.2025.101471_bib7","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.conctc.2025.101471_bib8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/art.37795","article-title":"Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004","volume":"65","author":"Feldman","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.conctc.2025.101471_bib9","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/rheumatology\/keu406","article-title":"The clinically quiescent phase in early-diagnosed SLE patients: inception cohort study","volume":"54","author":"Kasitanon","year":"2015","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.conctc.2025.101471_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s40258-014-0085-x","article-title":"Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes","volume":"12","author":"Oglesby","year":"2014","journal-title":"Appl. Health Econ. Health Pol."},{"issue":"suppl_1","key":"10.1016\/j.conctc.2025.101471_bib11","first-page":"i3","article-title":"Systemic lupus erythematosus diagnosis and management","volume":"56","author":"Thong","year":"2017","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.conctc.2025.101471_bib12","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3899\/jrheum.100007","article-title":"Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome","volume":"37","author":"Steiman","year":"2010","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.conctc.2025.101471_bib13","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/art.22356","article-title":"Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus","volume":"55","author":"Ng","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.conctc.2025.101471_bib14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.semarthrit.2020.05.009","article-title":"Addressing the rheumatology workforce shortage: a multifaceted approach","volume":"50","author":"Miloslavsky","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"issue":"24","key":"10.1016\/j.conctc.2025.101471_bib15","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.conctc.2025.101471_bib16","first-page":"447","article-title":"The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus","volume":"86","author":"Hay","year":"1993","journal-title":"Q. J. Med."},{"issue":"5 Suppl 39","key":"10.1016\/j.conctc.2025.101471_bib17","first-page":"S120","article-title":"Assessment of systemic lupus erythematosus","volume":"23","author":"Lam","year":"2005","journal-title":"Clin. Exp. Rheumatol."},{"issue":"9","key":"10.1016\/j.conctc.2025.101471_bib18","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1136\/annrheumdis-2013-205171","article-title":"Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort","volume":"74","author":"Bruce","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.conctc.2025.101471_bib19","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.3899\/jrheum.090019","article-title":"Prevalence of flare and influence of demographic and serologic factors on flare risk in systemic lupus erythematosus: a prospective study","volume":"36","author":"Petri","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.conctc.2025.101471_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/808391","article-title":"Healthcare utilization and costs of systemic lupus erythematosus in Medicaid","author":"Kan","year":"2013","journal-title":"BioMed Res. Int."},{"issue":"Suppl 1","key":"10.1016\/j.conctc.2025.101471_bib21","first-page":"S427","article-title":"Evaluation of damage index and its association with risk factors in patients with systemic lupus erythematosus","volume":"16","author":"Bonakdar","year":"2011","journal-title":"J. Res. Med. Sci. : the official journal of Isfahan University of Medical Sciences"},{"issue":"1","key":"10.1016\/j.conctc.2025.101471_bib22","article-title":"Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus-the Hopkins Lupus Cohort","volume":"2","author":"Al","year":"2015","journal-title":"Lupus science & medicine"},{"issue":"10","key":"10.1016\/j.conctc.2025.101471_bib23","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1177\/0961203316652489","article-title":"Why targeted therapies are necessary for systemic lupus erythematosus","volume":"25","author":"Durcan","year":"2016","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.conctc.2025.101471_bib24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.autrev.2014.01.055","article-title":"Optimizing outcome in SLE: treating-to-target and definition of treatment goals","volume":"13","author":"Doria","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"10.1016\/j.conctc.2025.101471_bib25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrrheum.2009.106","article-title":"The socioeconomic burden of SLE","volume":"5","author":"Lau","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.conctc.2025.101471_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000874","article-title":"A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort","volume":"10","author":"Ugarte-Gil","year":"2023","journal-title":"Lupus science & medicine"},{"issue":"14","key":"10.1016\/j.conctc.2025.101471_bib27","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1177\/0961203312458842","article-title":"Benefits of a self-management program in low-income African-American women with systemic lupus erythematosus: results of a pilot test","volume":"21","author":"Drenkard","year":"2012","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.conctc.2025.101471_bib28","first-page":"256","article-title":"Effect of a self-management program on patients with chronic disease","volume":"4","author":"Lorig","year":"2001","journal-title":"Effect Clin. Pract."},{"issue":"5","key":"10.1016\/j.conctc.2025.101471_bib29","first-page":"1112","article-title":"Does self-management lead to sustainable health benefits in people with arthritis? A 2-year transition study of 452 Australians","volume":"34","author":"Osborne","year":"2007","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.conctc.2025.101471_bib30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/1932296813519311","article-title":"Telehealth remote monitoring systematic review: structured self- monitoring of blood glucose and impact on A1C","volume":"8","author":"Greenwood","year":"2014","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.conctc.2025.101471_bib31","article-title":"Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus","volume":"3","author":"Pal","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.conctc.2025.101471_bib32","first-page":"491","article-title":"ANMCO\/SIC\/SIT Consensus document: the future of telemedicine in heart failure","volume":"17","author":"Di Lenarda","year":"2016","journal-title":"G. Ital. Cardiol."},{"issue":"2 suppl","key":"10.1016\/j.conctc.2025.101471_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/2047487316670256","article-title":"eHealth in cardiovascular medicine: a clinical update","volume":"23","author":"Saner","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.conctc.2025.101471_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2016.11","article-title":"The mPower study, Parkinson disease mobile data collected using ResearchKit","volume":"3","author":"Bot","year":"2016","journal-title":"Sci. Data"},{"issue":"10","key":"10.1016\/j.conctc.2025.101471_bib35","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/acr.23768","article-title":"Detection of flares by decrease in physical activity, collected using wearable activity trackers, in rheumatoid arthritis or axial spondyloarthritis: an application of Machine-Learning analyses in rheumatology","volume":"71","author":"Gossec","year":"2019","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.conctc.2025.101471_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8142368","article-title":"Biologics in the treatment of lupus erythematosus: a critical literature review","volume":"2019","author":"Samotij","year":"2019","journal-title":"BioMed Res. Int."},{"issue":"6","key":"10.1016\/j.conctc.2025.101471_bib37","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1016\/S2665-9913(22)00107-2","article-title":"Physician global assessment international standardisation COnsensus in systemic lupus erythematosus: the PISCOS study","volume":"4","author":"Piga","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.conctc.2025.101471_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13075-015-0702-6","article-title":"Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research","volume":"17","author":"Mikdashi","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.conctc.2025.101471_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13075-016-1087-x","article-title":"Impact of heart rate variability, a marker for cardiac health, on lupus disease activity","volume":"18","author":"Thanou","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.conctc.2025.101471_bib40","first-page":"373","article-title":"The systemic lupus international collaborating clinics\/American College of rheumatology (SLICC\/ACR) damage index for systemic lupus erythematosus international comparison","volume":"27","author":"Gladman","year":"2000","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.conctc.2025.101471_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001586","article-title":"Validation of a machine learning approach to estimate Systemic Lupus Erythematosus Disease Activity Index score categories and application in a real-world dataset","volume":"7","author":"Alves","year":"2021","journal-title":"RMD Open"},{"issue":"5","key":"10.1016\/j.conctc.2025.101471_bib42","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1191\/096120300678828433","article-title":"Accuracy of medical record scoring of the SLICC\/ACR damage index for systemic lupus erythematosus","volume":"9","author":"Thumboo","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.conctc.2025.101471_bib43","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/art.38573","article-title":"Pro-inflammatory adaptive cytokines and shed tumor necrosis factor receptors are elevated preceding systemic lupus erythematosus disease flare","volume":"66","author":"Munroe","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.conctc.2025.101471_bib44","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaut.2016.12.005","article-title":"Pathways of impending disease flare in African-American systemic lupus erythematosus patients","volume":"78","author":"Munroe","year":"2017","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.conctc.2025.101471_bib45","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/art.42389","article-title":"A flare risk index informed by select immune mediators in systemic lupus erythematosus","volume":"75","author":"Munroe","year":"2023","journal-title":"Arthritis Rheumatol."},{"issue":"12 Pt 1","key":"10.1016\/j.conctc.2025.101471_bib46","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00004","article-title":"The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial","volume":"142","author":"Buyon","year":"2005","journal-title":"Ann. Intern. Med."},{"issue":"e-pub","key":"10.1016\/j.conctc.2025.101471_bib47","article-title":"Clinical disease activity and flare in SLE: current concepts and novel biomarkers","volume":"119","author":"Thanou","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.conctc.2025.101471_bib48","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/annrheumdis-2024-eular.4561","article-title":"A lupus flare risk index informed by select adaptive and TNF superfamily immune mediators: validation in a confirmatory cohort","volume":"83","author":"Munroe","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.conctc.2025.101471_bib49","first-page":"256","article-title":"Effect of a self-management program for patients with chronic disease","volume":"4","author":"Lorig","year":"2001","journal-title":"Effect Clin. Pract."},{"issue":"10","key":"10.1016\/j.conctc.2025.101471_bib50","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/rheumatology\/keh605","article-title":"Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL)","volume":"44","author":"Leong","year":"2005","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.conctc.2025.101471_bib51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13075-020-2095-4","article-title":"Comparison of performance of specific (SLEQOL) and generic (SF36) health-related quality of life questionnaires and their associations with disease status of systemic lupus erythematosus: a longitudinal study","volume":"22","author":"Louthrenoo","year":"2020","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.conctc.2025.101471_bib52","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/0961203313476360","article-title":"Qualitative validation of the FACIT-fatigue scale in systemic lupus erythematosus","volume":"22","author":"Kosinski","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.conctc.2025.101471_bib53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s41687-021-00298-x","article-title":"Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised, double-blind, parallel-group controlled studies (BLISS-SC, BLISS-52, BLISS-76)","volume":"5","author":"Rendas-Baum","year":"2021","journal-title":"J Patient Rep Outcomes"},{"issue":"10","key":"10.1016\/j.conctc.2025.101471_bib54","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/acr.22349","article-title":"Development and validation of the Lupus Impact Tracker: a patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus","volume":"66","author":"Jolly","year":"2014","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.conctc.2025.101471_bib56","doi-asserted-by":"crossref","DOI":"10.2196\/41178","article-title":"Smartphone and wearable sensors for the estimation of facioscapulohumeral muscular dystrophy disease severity: cross-sectional study","volume":"7","author":"Zhuparris","year":"2023","journal-title":"JMIR Form Res"},{"issue":"3","key":"10.1016\/j.conctc.2025.101471_bib57","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000526438","article-title":"Remote monitoring of vital and activity parameters in chronic transfusion-dependent patients: a feasibility pilot using wearable biosensors","volume":"6","author":"Tonino","year":"2022","journal-title":"Digit. Biomark."},{"issue":"3","key":"10.1016\/j.conctc.2025.101471_bib58","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s13311-020-00868-9","article-title":"Finding suitable clinical endpoints for a potential treatment of a rare genetic disease: the case of ARID1B","volume":"17","author":"Kruizinga","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.conctc.2025.101471_bib59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-59745-530-5_3","article-title":"Descriptive statistics","volume":"404","author":"Nick","year":"2007","journal-title":"Methods Mol. Biol."},{"issue":"21","key":"10.1016\/j.conctc.2025.101471_bib60","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.3390\/healthcare12212151","article-title":"The effect of self-management on patients with chronic diseases: a systematic review and meta-analysis","volume":"12","author":"Huang","year":"2024","journal-title":"Healthcare"},{"key":"10.1016\/j.conctc.2025.101471_bib61","doi-asserted-by":"crossref","DOI":"10.2196\/17776","article-title":"The effectiveness of self-management of hypertension in adults using mobile health: systematic review and meta-analysis","volume":"8","author":"Li","year":"2020","journal-title":"JMIR Mhealth Uhealth"},{"key":"10.1016\/j.conctc.2025.101471_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166718","article-title":"T2DM self-management via smartphone applications: a systematic review and meta-analysis","volume":"11","author":"Cui","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.conctc.2025.101471_bib63","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.2337\/dc16-0346","article-title":"Do mobile phone applications improve glycemic control (HbA1c) in the self-management of diabetes? A systematic review, meta-analysis, and GRADE of 14 randomized trials","volume":"39","author":"Hou","year":"2016","journal-title":"Diabetes Care"}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865425000456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865425000456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T18:07:57Z","timestamp":1762625277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865425000456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":62,"alternative-id":["S2451865425000456"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2025.101471","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of a digital platform and flare risk blood biomarker index on lupus: A study protocol design for evaluating self efficacy and disease management","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2025.101471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Progentec Diagnostics, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101471"}}